CapEx at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's capex?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported capex of $161K in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's capex changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's capex increased by 62.6% year-over-year, from $99K to $161K.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's capex?
- Over 2 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's capex has grown at a 94.4% compound annual growth rate (CAGR), from $415K to $1.57M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.